Therapy Services: Axial/Spinal Decompression Therapy and Mechanical Traction (Provided in a Clinic Setting)
Customize your policy alerts
Sign up for all american_specialty_health policy alerts
Know when american_specialty_health releases new policies or updates existing guidance.
Monitor payer policy activity
Defines medical necessity, investigational status, and coding for axial/spinal decompression therapy and mechanical (cervical, lumbar, thoracic) traction provided in a clinic setting for Cigna/ASH-administered plans.
No material clinical or coverage changes in this revision.
Coverage Criteria
Cervical (medically necessary)
Covered when ALL of the following are met:
All bullets from policy chunk 4 apply
Lumbar (medically necessary)
Covered when ALL of the following are met:
These guidelines are not relevant to axial or spinal decompression therapy
Thoracic (not medically necessary)
See chunk 7
Axial/Spinal Decompression (experimental/unproven)
Devices listed in chunk 6 and background description in chunks 16 and 18.
Coverage considerations (evidence-informed)
Coverage stance informed by evidence summary
This logic reflects themes in the literature: overall insufficient evidence for isolated traction, occasional short-term benefit in subgroups, and recommendations favoring active therapies.
Overall clinical coverage stance
Summary stance derived from literature review in this section
Concluded explicitly in chunk 44; multiple RCTs and systematic reviews cited show no consistent benefit (chunks 36, 38, 42).
These guideline statements clarify that the lumbar mechanical traction criteria do not apply to axial/spinal decompression therapies. In addition, the policy identifies that mechanical traction applied to thoracic conditions is not covered under the guideline and lists CPT 97012 (traction, mechanical) as a procedure that is considered not medically necessary when used for thoracic or other spinal conditions not meeting the specified criteria.
The literature review concludes there is insufficient evidence to support the isolated use of mechanical traction or decompression as a standalone treatment for chronic low back pain. The policy notes multiple systematic reviews and trials that do not demonstrate clear benefit for isolated traction and indicates payers may exclude or deny coverage when traction/decompression is offered without documented prior conservative care.
The document explicitly states that current literature does not provide adequate scientific evidence that axial/spinal decompression is an effective single intervention or consistent adjunct to conservative therapy for back pain. It further notes axial/spinal decompression devices have not been adequately studied as alternatives to back surgery.
Within the referenced sections of the policy text provided, there are no additional explicit coverage exclusions beyond those stated elsewhere; the references list supports the literature synthesis but do not themselves add separate exclusion language.
Cervical mechanical traction is covered only when the policy's specific criteria are met and is explicitly stated to be not medically necessary when those criteria are not satisfied. Mechanical traction applied to the thoracic spine is specifically identified as not medically necessary. The policy also lists CPT 97012 (mechanical traction) as not medically necessary when used for thoracic or other conditions not meeting guideline criteria.
Given the limited quantity and generally low quality of evidence cited (including systematic reviews and randomized trials with methodological limitations), the policy states that traction tables/devices and nonsurgical axial/spinal decompression are not supported as effective treatments for routine management of neck and back pain when offered in isolation. The policy highlights substantial patient burdens (cost, time, marketing concerns) and uncertainty about treatment effect.
Several randomized controlled trials and systematic reviews summarized in the policy report no difference between motorized decompression/traction and sham or control interventions. Individual studies and audits that showed apparent improvements are noted to have methodological limitations; higher-quality trials generally did not demonstrate superiority of decompression devices over control or standard conservative approaches.
No additional explicit not-medically-necessary declarations are present in the provided reference list beyond the policy language and conclusions drawn in the literature review.
Coding
| 97012 | Application of a modality to 1 or more areas; traction, mechanical |
| 97012 | Application of a modality to 1 or more areas; traction, mechanical |
| S9090 | Vertebral axial decompression, per session |
| No procedure or CPT/HCPCS codes listed in these chunks | Document section contains literature and references; billing codes not specified in provided text. |
Provider Actions & Requirements
Coding and prior authorization note
Services should be billed with the CPT/HCPCS codes listed in the Coding section; specifically, CPT 97012 is the code for mechanical traction when medically necessary and HCPCS S9090 (vertebral axial decompression, per session) is considered experimental/investigational and not covered when billed as vertebral axial decompression per session.
Prior authorization for decompression/traction
Prior authorization is expected for nonsurgical axial/spinal decompression or mechanical traction provided in clinic settings to confirm medical necessity and that appropriate conservative care has been attempted.
- Prior authorization is used to confirm medical necessity given insufficient high-quality evidence of effectiveness and recognized burdens to members.
- Authorization should document that recommended conservative treatments were tried and failed per policy criteria.
Prior authorization and justification likely needed
Prior authorization and supporting justification will likely be required when decompression is requested because the policy concludes evidence is insufficient for decompression as a standalone effective therapy and short‑term or mixed benefits are of low quality.
- Documentation should explain why standard conservative treatments were insufficient and why decompression is being requested.
- Expect reviewers to assess study quality and the lack of consistent superiority of decompression over other therapies.
Prior authorization
No specific prior authorization program instructions or code-based authorization requirements are specified in the reference lists of this document excerpt.
- Check the applicable benefit plan or utilization management program for any payer-specific authorization rules.
Step requirement: trial of conservative care
Mechanical traction should be used only after failure of other evidence‑based therapeutic procedures for at least 3 weeks and only in combination with other evidence‑based treatments including therapeutic exercise.
- For cervical traction: failure of other evidence-based procedures for 3 weeks and used with therapeutic exercise (exercise must not aggravate or peripheralize symptoms).
- For lumbar traction: failure of other evidence-based procedures for 3 weeks and used with therapeutic exercise with extension movements (exercise must not aggravate or peripheralize symptoms).
Require trial of active interventions before traction
Evidence favors active interventions (for example exercise and core stability programs) over passive traction for chronic low back pain; require documentation of trials of active therapy prior to approving mechanical traction.
- Core stability exercise showed superior improvement versus intermittent traction in a randomized trial.
- Systematic reviews and guidelines summarize that passive modalities like traction are generally ineffective and recommend active treatments.
Require trial of conventional traction or PT before decompression
Randomized trials comparing nonsurgical decompression to conventional motorized traction or physiotherapy generally found no superiority of decompression; prior authorization may require documentation that conventional traction or standardized physical therapy were attempted.
- Koçak et al. (2017) found NSD was not superior to conventional motorized traction (no significant differences between groups).
- Demirel et al. (2017) showed adding NSDT did not confer additional benefits versus physiotherapy in controlled trial.
Required documentation and correct coding on claims
Providers must submit claims using the most appropriate CPT/HCPCS codes as of the date of service and include documentation that applicable policy criteria are met.
Documentation should include objective baseline measures and justification
Documentation submitted with requests should include objective baseline measures, diagnostic imaging or clinical findings supporting the target diagnosis, and justification for trial of traction versus established conservative care because many trials lacked blinding or comparison groups.
- Provide objective findings (e.g., peripheralization with movement, positive crossed SLR, imaging showing disc herniation) when applicable.
- Document prior conservative therapies and duration (e.g., ≥3 weeks) and response.
Document limitations of the evidence and supply objective supporting data
Documentation should note that many studies cited lacked control groups or had small sample sizes and that randomized controlled trials are needed; include indication, prior conservative therapy, and supporting objective imaging or exam findings when applicable.
- Cite pertinent imaging (e.g., MRI) or clinical tests that justify use of traction for the specific patient.
- Document duration and type of prior conservative management and objective response.
Denial triggers: unsupported diagnosis or non‑indicated spine region
Claims for services billed without covered diagnosis or procedure codes listed in this policy will be denied; mechanical traction (CPT 97012) performed for thoracic conditions or other spinal conditions not meeting guideline criteria is considered not medically necessary and may be denied.
- Verify the target diagnosis meets the policy criteria for cervical or lumbar traction before billing.
- Do not bill CPT 97012 for thoracic traction or other non‑indicated spinal uses covered as not medically necessary.
Denial risk due to high member burden and limited evidence
High out-of-pocket costs and unsubstantiated or misleading marketing around nonsurgical axial/spinal decompression have been recognized as significant burdens; payers may deny coverage when the evidence is lacking and member burden is high.
- Consideration of member financial/time burden may influence coverage decisions when clinical benefit is uncertain.
Denial risk for decompression requested as sole therapy
Because the evidence does not demonstrate that axial/spinal decompression is an effective single intervention or adequate alternative to back surgery, requests solely for decompression devices or decompression as a single therapy may be at risk for denial.
- The policy states devices have not been adequately studied as alternatives to back surgery and overall scientific evidence is inadequate to support decompression as a standalone therapy.
Background
Mechanical traction is described as a therapeutic method intended to relieve pain by stretching and separating vertebrae to reduce nerve pressure and disc stress. The policy also defines nonsurgical axial/spinal decompression as an intermittent motorized traction technique performed on specialized computerized tables (e.g., DRS, DRX series, VAX-D) intended to reduce intradiscal pressure and promote retraction of herniated disc material, and notes that evidence for these decompression systems is lacking and of low quality.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.